Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

The Dendreon Possibility

|Includes: Dendreon Corporation (DNDN), JNJ, JPM

The news that Dendreon - DNDN - is looking for a buyer sets up some intriguing trade scenarios.The partnership with JP Morgan Chase -JPM - raises the bar that a deal will include some heavy hitters in the Big Pharma space.Johnson and Johnson -JNJ - has Zytiga in this Prostate Cancer Drug arena and might be a candidate to take out one of it's competitors.Or at least prevent one of their many rivals from acquiring it.With short interest at around 40% in DNDN, a huge trading possibility is being set up.Since this news is fluid more attention is warranted.Will Dendreon have one more price spike-up before fading into the Sunset? Or will this be another false start in a long line of disappointments in the company's history? This week will shine the light on this mysterious stock that not many people on Wall Street seem to like.High Stakes trading has a way to temper all emotion with profits on the line.

Disclosure: I am long DNDN.